Engineered Virus and Immunotherapy: New Hope for Glioblastoma Brain Cancer Patients

A new study details the safe and promising use of an engineered oncolytic virus (DNX-2401) alongside immunotherapy in treating recurrent glioblastoma (GBM). Despite not meeting its primary efficacy endpoint, the study achieved a significant 12-month survival rate, exceeding the prespecified efficacy threshold.

from Neuroscience News https://ift.tt/DwAtlGJ

Comments

Reading Minds to Understand Human Tool Use

Combining brain imaging data with machine learning, researchers make new discoveries about how the brain controls the hand. The findings could lead to the development of more advanced neuroprosthetics. from Neuroscience News https://ift.tt/3tv7BbC

Large-scale acoustic-driven neuronal patterning and directed outgrowth

from Neurology : nature.com subject feeds https://ift.tt/3db3ZET

Topical ripasudil stimulates neuroprotection and axon regeneration in adult mice following optic nerve injury

from Neurology : nature.com subject feeds https://ift.tt/3036jc1

NEURO

Search This Blog